These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6147145)

  • 41. O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors.
    Lenz T; Werle E; Strobel G; Weicker H
    Can J Physiol Pharmacol; 1991 Jul; 69(7):929-37. PubMed ID: 1683267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological intervention with platelet phospholipase A2.
    Nosal R; Jancinova V
    Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
    Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
    Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Thromb Res; 1992 Dec; 68(4-5):333-44. PubMed ID: 1363256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa).
    Wang JP; Hsu MF; Teng CM
    Am J Chin Med; 1985; 13(1-4):109-18. PubMed ID: 3927704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M
    Gen Pharmacol; 1991; 22(5):773-8. PubMed ID: 1684769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat.
    Emms H; Lewis GP
    Br J Pharmacol; 1986 Jan; 87(1):109-15. PubMed ID: 3082399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid.
    Aharony D; Smith JB; Silver MJ
    Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.